Related references
Note: Only part of the references are listed.Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2021)
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
Aron Bartha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010
Wieslaw Kanadys et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Premenopausal Breast Cancer Risk Factors and Associations with Molecular Subtypes: A Case-Control Study
Faustin Ntirenganya et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2021)
Heterogeneity within molecular subtypes of breast cancer
Kevin M. Turner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)
A FACS-Free Purification Method to Study Estrogen Signaling, Organoid Formation, and Metabolic Reprogramming in Mammary Epithelial Cells
Aurelie Lacouture et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Factors for the Primary Prevention of Breast Cancer: A Meta-Analysis of Prospective Cohort Studies
Jalal Poorolajal et al.
JOURNAL OF RESEARCH IN HEALTH SCIENCES (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Role of STAT3 signaling pathway in breast cancer
Jia-hui Ma et al.
CELL COMMUNICATION AND SIGNALING (2020)
Role of Secreted Frizzled-Related Protein 1 in Early Mammary Gland Tumorigenesis and Its Regulation in Breast Microenvironment
Alisson Clemenceau et al.
CELLS (2020)
Pregnancy reprograms the epigenome of mammary epithelial cells and blocks the development of premalignant lesions
Mary J. Feigman et al.
NATURE COMMUNICATIONS (2020)
Secreted Frizzled-Related Protein 1 as a Biomarker against Incomplete Age-Related Lobular Involution and Microcalcifications' Development
Alisson Clemenceau et al.
CANCERS (2020)
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Janos T. Fekete et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
GENT2: an updated gene expression database for normal and tumor tissues
Seung-Jin Park et al.
BMC MEDICAL GENOMICS (2019)
Association of Microcalcification Clusters with Short-term Invasive Breast Cancer Risk and Breast Cancer Risk Factors
Maya Alsheh Ali et al.
SCIENTIFIC REPORTS (2019)
Gene expression signature of atypical breast hyperplasia and regulation by SFRP1
Kelly J. Gregory et al.
BREAST CANCER RESEARCH (2019)
c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer
Huan He et al.
ONCOGENE (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy
Qiong-Ni Zhu et al.
HEREDITAS (2018)
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
Charu Kothari et al.
Oncotarget (2018)
MYC-Driven Pathways in Breast Cancer Subtypes
Yassi Fallah et al.
BIOMOLECULES (2017)
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program
Merete Ellingjord-Dale et al.
BREAST CANCER RESEARCH (2017)
Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype
Xuezheng Sun et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients
Zibo Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Established breast cancer risk factors and risk of intrinsic tumor subtypes
Mollie E. Barnard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Estrogen-mediated signaling is differentially affected by the expression levels of Sfrp1 in mammary epithelial cells
Kelly J. Gregory et al.
CELL BIOLOGY INTERNATIONAL (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
An Epigenetic Memory of Pregnancy in the Mouse Mammary Gland
Camila O. dos Santos et al.
CELL REPORTS (2015)
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling
Christof Bernemann et al.
MOLECULAR CANCER (2014)
BDNF Is Associated with SFRP1 Expression in Luminal and Basal-Like Breast Cancer Cell Lines and Primary Breast Cancer Tissues: A Novel Role in Tumor Suppression?
Laura Huth et al.
PLOS ONE (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Lower Incidence but More Aggressive Behavior of Right Sided Breast Cancer in Pakistani Women: Does Right Deserve More Respect?
Nosheen Fatima et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Association between common risk factors and molecular subtypes in breast cancer patients
Fatma P. Turkoz et al.
BREAST (2013)
Positional Variations in Mammary Gland Development and Cancer
Jacqueline M. Veltmaat et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2013)
Loss of sfrp1 promotes ductal branching in the murine mammary gland
Kelly J. Gauger et al.
BMC DEVELOPMENTAL BIOLOGY (2012)
Subtype-specific alterations of the Wnt signaling pathway in breast cancer: Clinical and prognostic significance
Nupur Mukherjee et al.
CANCER SCIENCE (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger
Mia M. Gaudet et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Wnt signalling and its impact on development and cancer
Alexandra Klaus et al.
NATURE REVIEWS CANCER (2008)
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
E. Dahl et al.
ONCOGENE (2007)
The beginning of the end: Death signaling in early involution
Fiona O. Baxter et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2007)
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J. Veeck et al.
ONCOGENE (2006)
Cancer and laterality: A study of the five major paired organs (UK)
R Roychoudhuri et al.
CANCER CAUSES & CONTROL (2006)
Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene
DJ Jerry et al.
JOURNAL OF DAIRY SCIENCE (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Bio-morphological events in the development of the human female mammary gland from fetal age to puberty
AG Naccarato et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)
Share Paper
